Back to search

Article

Ductal pancreatic cancer interception by FGFR2 abrogation

2024-10-18

Abstract excerpt

<h4>ABSTRACT</h4> Activating KRAS mutations are a key feature of pancreatic ductal adenocarcinoma (PDA) and drive tumor initiation and progression. However, mutant KRAS by itself is weakly oncogenic. The pathways that cooperate with mutant KRAS to induce tumorigenesis are less-defined. Analyzing organoids and murine and human pancreatic specimens, we found that the receptor tyrosine kinase FGFR2 was progressively...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
382cc711-6bcd-58f4-827b-f206175c01a0
DOI
10.1101/2024.10.16.618726
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ductal pancreatic cancer interception by FGFR2 abrogationDOI 10.1101/2024.10.16.618726
Select a neighboring publication to make it the new centre.